---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020896"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T00:55:31.458743+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio announces $3.9M warrant exercise; issues new warrants for up to 8.6M shares

## Summary
- Existing warrant holders exercised 4,318,905 shares at reduced price $0.9047 (from $1.40); gross proceeds ~$3.9M.
- Holders receive new unregistered warrants to purchase up to 8,637,810 shares at $0.9047, 5-year term, exercisable after stockholder approval.
- Company to seek stockholder approval within 60 days; new warrants include cashless exercise after 6 months if registration not effective.
- Pays placement agent Ladenburg Thalmann 8% cash fee plus 6% warrants; net proceeds for working capital.

## SEC filing metadata
- accession: 0001641172-25-020896
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000164117225020896/0001641172-25-020896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000164117225020896/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020896
- JSON: https://secwatch.observer/filing/0001641172-25-020896.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020896.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.